Lupus: How much "complexity" is really (just) genetic heterogeneity?

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3661-3664

  Crow, Yanick J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; NOTE; ONSET AGE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC HETEROGENEITY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE;

EID: 82455198835     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30603     Document Type: Note

References (47)

1. Rahman A, Isenberg DA,. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-39. (Pubitemid 351397092)
2. Nightingale AL, Farmer RD, de Vries CS,. Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006; 15: 656-61. (Pubitemid 44404664)
3. Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008; 205: 1099-108. (Pubitemid 351679685)
4. Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M, et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008; 58: 2511-7.
5. Weckerle CE, Niewold TB,. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011; 40: 42-9.
6. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, et al, on behalf of the Grupo Latinoamericano de Estudio del Lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005; 52: 1138-47. (Pubitemid 40530121)
7. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-8.
8. Deng Y, Tsao BP,. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010; 6: 683-92.
9. So HC, Gui AH, Cherny SS, Sham PC,. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 2011; 35: 310-7.
10. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-53.
11. McClellan J, King MC,. Genetic heterogeneity in human disease. Cell 2010; 141: 210-7.
12. Botto M, Kirschfink M, Macor P, Pickering MC, Wurzner R, Tedesco F,. Complement in human diseases: lessons from complement deficiencies. Mol Immunol 2009; 46: 2774-83.
13. Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001; 28: 313-4. (Pubitemid 32702418)
14. Briggs TA, Rice GI, Daly S, Urquhart J, Gornall H, Bader-Meunier B, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 2011; 43: 127-31.
15. Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, et al. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet 2011; 43: 132-7.
16. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007; 39: 1065-7. (Pubitemid 47340647)
17. Burghes AH, Vaessin HE, de La Chapelle A,. Genetics: the land between Mendelian and multifactorial inheritance. Science 2001; 293: 2213-4. (Pubitemid 32900219)
18. Eichers ER, Lewis RA, Katsanis N, Lupski JR,. Triallelic inheritance: a bridge between Mendelian and multifactorial traits. Ann Med 2004; 36: 262-72. (Pubitemid 38789280)
19. Lupski JR,. New mutations and intellectual function. Nat Genet 2010; 42: 1036-8.
20. Vadlamudi L, Dibbens LM, Lawrence KM, Iona X, McMahon JM, Murrell W, et al. Timing of de novo mutagenesis-a twin study of sodium-channel mutations. N Engl J Med 2010; 363: 1335-40.
21. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20: 170-9.
22. Magerus-Chatinet A, Neven B, Stolzenberg MC, Daussy C, Arkwright PD, Lanzarotti N, et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest 2011; 121: 106-12.
23. Magerus-Chatinet A, Rieux-Laucat F,. The model of the two-hit of Knudson applies to the auto-immune diseases: the example of the lymphoproliferative syndrome with auto-immunity. Med Sci (Paris) 2011; 27: 107-9. In French.
24. Sandilands A, Terron-Kwiatkowski A, Hull PR, O'Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-4. (Pubitemid 46676107)
25. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009; 361: 1651-61.
26. Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009; 132: 1783-94.
27. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010; 42: 684-7.
28. Holm H, Gudbjartsson DF, Sulem P, Masson G, Helgadottir HT, Zanon C, et al. A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet 2011; 43: 316-20.
29. Antonarakis SE, Chakravarti A, Cohen JC, Hardy J,. Mendelian disorders and multifactorial traits: the big divide or one for all? Nat Rev Genet 2010; 11: 380-4.
30. Crow YJ, Rehwinkel J,. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009; 18: R130-6.
31. Aicardi J, Goutieres F,. Systemic lupus erythematosus or Aicardi-Goutieres syndrome? Neuropediatrics 2000; 31: 113. (Pubitemid 30495433)
32. Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 2007; 80: 811-5. (Pubitemid 46564418)
33. Ravenscroft JC, Suri M, Rice GI, Szynkiewicz M, Crow YJ,. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet A 2011; 155A: 235-7.
34. Alarcon-Riquelme ME,. Nucleic acid by-products and chronic inflammation. Nat Genet 2006; 38: 866-7. (Pubitemid 44141652)
35. Stetson DB, Ko JS, Heidmann T, Medzhitov R,. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008; 134: 587-98.
36. Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Ronnblom L, et al. C1q inhibits immune complex-induced interferon-α production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum 2009; 60: 3081-90.
37. Santer DM, Hall BE, George TC, Tangsombatvisit S, Liu CL, Arkwright PD, et al. C1q deficiency leads to the defective suppression of IFN-α in response to nucleoprotein containing immune complexes. J Immunol 2010; 185: 4738-49.
38. Behrens TW, Graham RR,. TRAPing a new gene for autoimmunity. Nat Genet 2011; 43: 90-1.
39. Murphy R, Ellard S, Hattersley AT,. Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 200-13. (Pubitemid 351430925)
40. Kono DH, Theofilopoulos AN,. Genetics of SLE in mice. Springer Semin Immunopathol 2006; 28: 83-96. (Pubitemid 46628478)
41. Morel L,. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 2010; 6: 348-57.
42. Sestak AL, Furnrohr BG, Harley JB, Merrill JT, Namjou B,. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 2011; 70 Suppl I: i37-43.
43. Brunner HI, Huggins J, Klein-Gitelman MS,. Pediatric SLE-towards a comprehensive management plan. Nat Rev Rheumatol 2011; 7: 225-33.
44. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5. (Pubitemid 36297546)
45. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-23. (Pubitemid 36350866)
46. Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis 2011; 70: 151-6.
47. Singleton AB, Hardy J, Traynor BJ, Houlden H,. Towards a complete resolution of the genetic architecture of disease. Trends Genet 2010; 26: 438-42.